Tenofovir + Lamivudine Tablets are antiretroviral medicines containing two nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs). The combination is used as part of antiretroviral therapy (ART) for the management of HIV-1 infection. Tenofovir and lamivudine can also have activity against hepatitis B virus (HBV), making HBV status an important consideration before treatment or discontinuation.
Understanding the recommended Tenofovir + Lamivudine dosage, precautions, monitoring requirements, possible interactions, and safe administration can help patients and healthcare professionals use the medicine appropriately.
What Are Tenofovir + Lamivudine Tablets?
Tenofovir and lamivudine work by inhibiting viral reverse transcriptase, an enzyme required for HIV replication. When used as part of an appropriate combination antiretroviral regimen, they help suppress HIV replication.
A commonly used fixed-dose combination contains Tenofovir Disoproxil Fumarate (TDF) 300 mg + Lamivudine 300 mg, although the exact strength and formulation can vary by product and market. Always check the product label and prescription before use.
The World Health Organization lists tenofovir 300 mg once daily and lamivudine 300 mg once daily as adult/adolescent doses in relevant antiretroviral regimens.
Tenofovir + Lamivudine Dosage Information
The appropriate dosage depends on the patient's age, body weight, kidney function, medical history, HIV treatment regimen, and the specific formulation prescribed.
For adults and appropriate adolescents, a commonly used fixed-dose tablet containing tenofovir disoproxil fumarate 300 mg and lamivudine 300 mg is taken once daily, when prescribed as part of an appropriate HIV treatment regimen.
How to Take Tenofovir + Lamivudine Tablets
- Take the tablet exactly as prescribed by a healthcare professional.
- Take it at approximately the same time every day.
- Swallow the tablet with water.
- Follow the instructions provided with the specific product.
- Do not change the dose or stop treatment without medical advice.
- If a dose is missed, follow the instructions provided by your healthcare professional or product information rather than taking additional tablets without guidance.
Consistent adherence is important because interruptions in antiretroviral treatment can create difficulties in maintaining effective HIV treatment. WHO emphasizes maintaining continuity of antiretroviral therapy when possible.
Kidney Function and Dose Considerations
Kidney function is an important consideration with tenofovir disoproxil fumarate. Prescribing information recommends assessing renal function before treatment and monitoring it during therapy as clinically appropriate. Tests may include serum creatinine, estimated creatinine clearance, urine glucose, and urine protein; serum phosphorus may also be assessed in patients with chronic kidney disease.
Patients with reduced kidney function may require a different dosing schedule or an alternative formulation. Fixed-dose Tenofovir + Lamivudine tablets may not be appropriate for every patient with renal impairment, because the individual components may require different dose adjustments.
Therefore, patients with kidney disease should not adjust their dose themselves.
Important Precautions Before Taking Tenofovir + Lamivudine
1. Hepatitis B Infection
Patients should be tested for hepatitis B before starting therapy. Both tenofovir and lamivudine have activity against HBV.
Stopping treatment in a person with HIV/HBV coinfection can result in a severe acute worsening of hepatitis B. Patients with HBV should therefore receive appropriate medical monitoring if therapy is discontinued or changed.
2. Kidney Problems
Tell your healthcare professional if you have:
- Kidney disease
- Reduced kidney function
- A history of kidney problems
- Conditions that may increase the risk of kidney impairment
Tenofovir disoproxil fumarate has been associated with renal toxicity, including renal impairment and Fanconi syndrome. Appropriate renal monitoring is recommended.
3. Bone Health
Tenofovir disoproxil fumarate-containing treatment may be associated with decreases in bone mineral density in some patients. Healthcare professionals may consider additional assessment in patients with risk factors for osteoporosis or bone loss.
4. Other Medicines
Tell your doctor or pharmacist about all medicines, supplements, and treatments you are taking.
Particular attention may be required with medicines that can affect kidney function or interact with tenofovir. The prescribing information specifically highlights concerns with certain nephrotoxic medicines and some antiretroviral agents.
5. HIV Treatment Should Be Clinically Managed
Tenofovir + Lamivudine is generally used as part of an appropriate antiretroviral treatment regimen for HIV. The combination should not be treated as a complete HIV regimen unless specifically prescribed as such.
Current WHO guidance commonly uses three-drug combination therapy, including regimens containing tenofovir, lamivudine, and dolutegravir.
Possible Side Effects of Tenofovir + Lamivudine
Like other medicines, Tenofovir + Lamivudine may cause adverse effects. The type and severity can vary between individuals.
Possible adverse effects can include:
- Nausea
- Diarrhea
- Headache
- Abdominal discomfort
- Fatigue
- Dizziness
- Rash
Some potentially serious reactions involve kidney function, bone health, liver disease, or metabolic abnormalities. Patients should seek medical attention if they develop concerning or severe symptoms.
The prescribing information also warns about rare but serious conditions such as lactic acidosis and severe hepatomegaly with steatosis associated with nucleoside analogues.
Who Should Take Special Care?
Medical advice is particularly important for people who:
- Have kidney disease
- Have chronic hepatitis B
- Have liver disease
- Have a history of bone loss
- Take medicines that may affect kidney function
- Are pregnant or planning pregnancy
- Take other HIV or antiviral medicines
- Have previously experienced adverse reactions to antiretroviral medicines
Your healthcare professional can determine whether Tenofovir + Lamivudine is appropriate based on your complete medical history.
Frequently Asked Questions
What is the usual Tenofovir + Lamivudine dosage?
A commonly used adult fixed-dose combination containing Tenofovir Disoproxil Fumarate 300 mg and Lamivudine 300 mg is taken once daily when prescribed as part of an appropriate HIV treatment regimen. The exact dosage must follow the specific product information and healthcare professional's instructions.
Can Tenofovir + Lamivudine be taken with food?
The administration instructions can depend on the specific product. Follow the prescribing information supplied with your medicine or the instructions given by your healthcare professional.
Can I stop Tenofovir + Lamivudine suddenly?
Do not stop treatment without medical advice. Stopping medicines containing tenofovir and lamivudine can be particularly important in people with hepatitis B because HBV can flare after discontinuation.
Is kidney testing required during treatment?
Kidney function assessment is recommended before and during treatment with tenofovir-containing products as clinically appropriate. Monitoring may include creatinine clearance and other laboratory tests.
Is Tenofovir + Lamivudine used for HIV?
Yes. Tenofovir and lamivudine are antiretroviral medicines used in combination with other antiretroviral agents for HIV-1 treatment.
Is Tenofovir + Lamivudine used for hepatitis B?
Both components have activity against HBV, but the appropriate treatment depends on the patient's diagnosis and clinical circumstances. HBV testing and medical evaluation are important before treatment decisions are made.
Conclusion
Tenofovir + Lamivudine Tablets are important antiretroviral medicines used as part of HIV treatment. Correct dosage, consistent adherence, kidney-function monitoring, awareness of hepatitis B status, and appropriate management of drug interactions are important aspects of safe treatment.
Patients should always use the strength and dosage prescribed for them and should not start, stop, or modify Tenofovir + Lamivudine treatment without professional medical guidance. Healthcare professionals should consult the current product-specific prescribing information when making dosing decisions.
Medical Disclaimer: This article is intended for general educational and informational purposes only. It does not replace professional medical advice, diagnosis, or treatment. Dosage and treatment decisions should be made by a qualified healthcare professional based on the patient's individual condition and the applicable product information.
